Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of Erenumab on Functional Impact of Migraine
NCT04465357Phase 4Completed
- Start
- Oct 2020
- Primary completion
- Jun 2022
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of erenumab in migraine. Started Oct 2020; status: completed.
02
Drugs
erenumab
03
Conditions
migraine
Beyond the preview
Go deeper on NCT04465357.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04465357.